Ajay Samkaria/LinkedIn
May 22, 2026, 13:36
Ajay Samkaria։ A Compatible Crossmatch Does Not Always Mean Complete Safety
Ajay Samkaria, Product and Application Manager India at Diagast, shared a post on LinkedIn:
“Crossmatch protects the present transfusion.
Antibody screening protects the patient’s future.
A compatible crossmatch does not always mean complete transfusion safety.
Some clinically significant antibodies may still go undetected unless proper antibody screening is performed.
That’s why modern transfusion medicine is shifting from: ‘minimum compatibility’ to ‘future transfusion safety.’
Think Beyond Crossmatch.
Think Antibody Screening.
Think Patient Safety.”
Stay updated with Hemostasis Today.
-
May 22, 2026, 13:31Mariam Swidan: Why Hemolysis Severity Matters in G6PD Deficiency
-
May 22, 2026, 13:25Augustina Isioma Ikusemoro: Why Plasma and RBC Transfusions Follow Different Compatibility Rules
-
May 22, 2026, 13:08Anas Hamad: Thrombosis as Overlooked Clinical Challenge in APL
-
May 22, 2026, 12:29Neema Ngugi: Highlighting 6 Major Types of Anemia
-
May 22, 2026, 12:27Jacinto López Sagaseta: Solving the Structural Puzzle of FVIIa–EPCR Interaction
-
May 22, 2026, 12:25Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms
-
May 22, 2026, 11:52Prakash W. Kamat: Highlighting the Role of Physical Activity in Hemophilia Management
-
May 22, 2026, 11:43Mohamed Hanafy Morsy: Understanding Hemochromatosis – Genetics Made Simple
-
May 22, 2026, 10:23Rucha Patil: Insights from The National Haemophilia Conclave 2026